These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35849446)

  • 21. Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.
    Baheti G; Kiser JJ; Havens PL; Fletcher CV
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5294-9. PubMed ID: 21896913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.
    Yang S; Lukey P; Beerahee M; Hoke F
    Clin Pharmacokinet; 2013 Mar; 52(3):187-98. PubMed ID: 23254770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials.
    Klünder B; Mittapalli RK; Mohamed MF; Friedel A; Noertersheuser P; Othman AA
    Clin Pharmacokinet; 2019 Aug; 58(8):1045-1058. PubMed ID: 30945116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of zonisamide after oral administration in healthy Chinese volunteers.
    Qiu X; Dai Q; Sun F; Liu Y; Yang B; Xiang R; Yu M; Xiong L; Bi S; Lu W; Chen Y; Xia P
    Int J Clin Pharmacol Ther; 2016 May; 54(5):362-8. PubMed ID: 27007995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.
    Xu FY; Huang JH; He YC; Liang LY; Li LJ; Yang J; Yin F; Xu L; Zheng QS; Wang K
    Acta Pharmacol Sin; 2017 Nov; 38(11):1580-1588. PubMed ID: 28713157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of eperisone following oral administration in healthy Korean volunteers.
    Baek IH; Back HM; Chae JW; Ha ES; Park H; Choi DH; Staatz CE; Kim MS
    Biopharm Drug Dispos; 2021 Mar; 42(2-3):94-102. PubMed ID: 33527395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of effect of impaired renal function on lamivudine pharmacokinetics.
    Bouazza N; Tréluyer JM; Ghosn J; Hirt D; Benaboud S; Foissac F; Viard JP; Urien S
    Br J Clin Pharmacol; 2014 Oct; 78(4):847-54. PubMed ID: 24750102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
    Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L
    Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite.
    Narwal R; Akhlaghi F; Asberg A; Hermann M; Rosenbaum SE
    Clin Pharmacokinet; 2010 Oct; 49(10):693-702. PubMed ID: 20818835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites.
    Willavize S; Fiedler-Kelly J; Ludwig E; Guan L
    J Clin Pharmacol; 2017 Feb; 57(2):255-265. PubMed ID: 27436172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of mizoribine in adult recipients of renal transplantation.
    Ishida K; Okamoto M; Ishibashi M; Hashimoto Y
    Clin Exp Nephrol; 2011 Dec; 15(6):900-6. PubMed ID: 21751083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and tolerability of febuxostat after oral administration in healthy Chinese volunteers: a randomized, open-label, singleand multiple-dose three-way crossover study.
    Zhou H; Zheng Y; Wu G; Hu X; Zhai Y; Iv D; Liu J; Wu L; Shentu J
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):115-24. PubMed ID: 26636422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. African American patients with gout: efficacy and safety of febuxostat vs allopurinol.
    Wells AF; MacDonald PA; Chefo S; Jackson RL
    BMC Musculoskelet Disord; 2012 Feb; 13():15. PubMed ID: 22316106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic analysis of istradefylline in healthy subjects and in patients with Parkinson's disease.
    Knebel W; Rao N; Uchimura T; Mori A; Fisher J; Gastonguay MR; Chaikin P
    J Clin Pharmacol; 2011 Jan; 51(1):40-52. PubMed ID: 20200269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.
    Jullien V; Tréluyer JM; Chappuy H; Dimet J; Rey E; Dupin N; Salmon D; Pons G; Urien S
    Br J Clin Pharmacol; 2005 Feb; 59(2):183-8. PubMed ID: 15676040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The population pharmacokinetics of allopurinol and oxypurinol in patients with gout.
    Wright DF; Stamp LK; Merriman TR; Barclay ML; Duffull SB; Holford NH
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1411-21. PubMed ID: 23475133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer.
    Emoto-Yamamoto Y; Iida S; Kawanishi T; Fukuoka M
    J Clin Pharm Ther; 2015 Apr; 40(2):232-9. PubMed ID: 25402940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.